Announced Sat, 17 Oct, 2026 · 17:22 IST

Board meeting on Oct 28 to approve Q2 FY26 financial results

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.3%Reaction day

₹43.00

prior close

₹42.01

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.7%+1.4% vs market

Pharmaceuticals peers, median of 172sector-1.6%+1.3% vs sector

On the reaction day the stock moved 1.4 pts more than Nifty Microcap 250 and 1.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.3-1.7+1.4-1.6+1.3

Next day

-4.5-4.2-0.3-3.5-1.1

-8.1-5.2-2.9-3.7-4.5

-6.3-7.4+1.2-5.3-1.0

-8.8-7.0-1.8-4.1-4.7

-10.7-5.5-5.2-2.3-8.4

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zenotech Laboratories has informed BSE that its Board of Directors will meet on October 28, 2026 to consider and approve the Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2026. The trading window for dealing in shares remains closed until October 30, 2026, around 48 hours after the results declaration.

Likely market impact

No immediate financial impact. Q2 and H1 FY26 results to be announced after the board meeting on October 28. Trading window closed until October 30.